NXY-059
- 1 October 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (10) , 2649-2650
- https://doi.org/10.1161/01.str.0000240511.22775.a7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- NXY-059 for Acute Ischemic StrokeNew England Journal of Medicine, 2006
- Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral IschemiaStroke, 2005
- Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiologyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Targets for Vascular Protection After Acute Ischemic StrokeStroke, 2004
- Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scoresExperimental Neurology, 2004
- Functional and Histological Evidence for the Protective Effect of NXY-059 in a Primate Model of Stroke When Given 4 Hours After OcclusionStroke, 2003
- Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human StrokeCirculation, 2003
- Effect of NXY‐059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time windowBritish Journal of Pharmacology, 2002
- Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1999
- Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoterCancer Letters, 1996